Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report)'s stock price was down 2.3% during trading on Monday . The company traded as low as $1.28 and last traded at $1.29. Approximately 69,530 shares were traded during trading, a decline of 31% from the average daily volume of 100,555 shares. The stock had previously closed at $1.32.
Analyst Upgrades and Downgrades
Separately, HC Wainwright reiterated a "buy" rating and set a $4.00 price target on shares of Vivani Medical in a research report on Monday, May 19th.
Check Out Our Latest Stock Analysis on VANI
Vivani Medical Trading Up 0.8%
The business has a fifty day simple moving average of $1.14 and a 200 day simple moving average of $1.13.
Vivani Medical (NASDAQ:VANI - Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.01). Equities research analysts expect that Vivani Medical, Inc. will post -0.41 EPS for the current fiscal year.
Insider Activity
In other news, Director Gregg Williams bought 44,400 shares of the firm's stock in a transaction on Monday, April 7th. The shares were bought at an average cost of $0.99 per share, for a total transaction of $43,956.00. Following the acquisition, the director directly owned 4,799,200 shares of the company's stock, valued at $4,751,208. This trade represents a 0.93% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders have bought a total of 80,662 shares of company stock valued at $80,766 over the last ninety days. Corporate insiders own 46.40% of the company's stock.
Institutional Trading of Vivani Medical
Several hedge funds have recently made changes to their positions in the company. Wealthedge Investment Advisors LLC acquired a new position in Vivani Medical in the fourth quarter valued at approximately $43,000. Jane Street Group LLC purchased a new stake in Vivani Medical in the fourth quarter valued at $66,000. Northern Trust Corp lifted its stake in shares of Vivani Medical by 19.1% in the 4th quarter. Northern Trust Corp now owns 71,915 shares of the company's stock valued at $83,000 after purchasing an additional 11,540 shares during the last quarter. Finally, Connective Capital Management LLC grew its holdings in shares of Vivani Medical by 796.2% during the 1st quarter. Connective Capital Management LLC now owns 162,098 shares of the company's stock worth $170,000 after purchasing an additional 144,010 shares during the period. Hedge funds and other institutional investors own 6.78% of the company's stock.
Vivani Medical Company Profile
(
Get Free Report)
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Further Reading
Before you consider Vivani Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivani Medical wasn't on the list.
While Vivani Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.